Literature DB >> 19632124

ADMET rules of thumb II: A comparison of the effects of common substituents on a range of ADMET parameters.

Paul Gleeson1, Gianpaolo Bravi, Sandeep Modi, Daniel Lowe.   

Abstract

A systematic analysis of data generated in key in vitro assays within GSK has been undertaken to identify what impact a range of common substituents have on a range of ADMET parameters. These include; P450 1A2, 2C9, 2C19, 2D6 and 3A4 inhibition, hERG inhibition, phosphate buffer solubility and artificial membrane permeability. We do this by identifying all matched molecular pairs, differing by the replacement of a hydrogen atom with a list of predefined substituents. For each substituent we calculate the mean difference in the ADMET parameter for all the matched molecular pairs identified, making a statistical assessment of the difference, as well as assessing the diversity for each example to ensure that the results can be generalized. We also relate the change in activity observed for each substituent to differences in their molecular properties in an effort to identify any structural alerts.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19632124     DOI: 10.1016/j.bmc.2009.07.002

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  18 in total

Review 1.  Chemical predictive modelling to improve compound quality.

Authors:  John G Cumming; Andrew M Davis; Sorel Muresan; Markus Haeberlein; Hongming Chen
Journal:  Nat Rev Drug Discov       Date:  2013-12       Impact factor: 84.694

2.  Using Caenorhabditis elegans to study serpinopathies.

Authors:  Olivia S Long; Sager J Gosai; Joon Hyeok Kwak; Dale E King; David H Perlmutter; Gary A Silverman; Stephen C Pak
Journal:  Methods Enzymol       Date:  2011       Impact factor: 1.600

Review 3.  Scaffold-hopping as a strategy to address metabolic liabilities of aromatic compounds.

Authors:  Phillip R Lazzara; Terry W Moore
Journal:  RSC Med Chem       Date:  2019-12-16

4.  Compilation and physicochemical classification analysis of a diverse hERG inhibition database.

Authors:  Remigijus Didziapetris; Kiril Lanevskij
Journal:  J Comput Aided Mol Des       Date:  2016-10-25       Impact factor: 3.686

5.  Trainable structure-activity relationship model for virtual screening of CYP3A4 inhibition.

Authors:  Remigijus Didziapetris; Justas Dapkunas; Andrius Sazonovas; Pranas Japertas
Journal:  J Comput Aided Mol Des       Date:  2010-09-01       Impact factor: 3.686

6.  LogD Contributions of Substituents Commonly Used in Medicinal Chemistry.

Authors:  Matthew L Landry; James J Crawford
Journal:  ACS Med Chem Lett       Date:  2019-12-11       Impact factor: 4.345

7.  Strategies for the Catalytic Enantioselective Synthesis of α-Trifluoromethyl Amines.

Authors:  Chibueze I Onyeagusi; Steven J Malcolmson
Journal:  ACS Catal       Date:  2020-10-12       Impact factor: 13.084

8.  Elucidation of fluorine's impact on pKa and in vitro Pgp-mediated efflux for a series of PDE9 inhibitors.

Authors:  Kasper Fjelbye; Mauro Marigo; Rasmus P Clausen; Erling B Jørgensen; Claus T Christoffersen; Karsten Juhl
Journal:  Medchemcomm       Date:  2018-04-28       Impact factor: 3.597

9.  Automated high-content live animal drug screening using C. elegans expressing the aggregation prone serpin α1-antitrypsin Z.

Authors:  Sager J Gosai; Joon Hyeok Kwak; Cliff J Luke; Olivia S Long; Dale E King; Kevin J Kovatch; Paul A Johnston; Tong Ying Shun; John S Lazo; David H Perlmutter; Gary A Silverman; Stephen C Pak
Journal:  PLoS One       Date:  2010-11-12       Impact factor: 3.240

10.  An ultra high-throughput, whole-animal screen for small molecule modulators of a specific genetic pathway in Caenorhabditis elegans.

Authors:  Chi K Leung; Ying Wang; Siobhan Malany; Andrew Deonarine; Kevin Nguyen; Stefan Vasile; Keith P Choe
Journal:  PLoS One       Date:  2013-04-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.